Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Payables (2016 - 2025)

Historic Payables for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to $1.2 million.

  • CV Sciences' Payables fell 3563.1% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 3563.1%. This contributed to the annual value of $1.9 million for FY2024, which is 1663.06% down from last year.
  • Per CV Sciences' latest filing, its Payables stood at $1.2 million for Q3 2025, which was down 3563.1% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, CV Sciences' Payables ranged from a high of $4.0 million in Q1 2021 and a low of $1.2 million during Q3 2025
  • Over the past 5 years, CV Sciences' median Payables value was $2.3 million (recorded in 2024), while the average stood at $2.4 million.
  • In the last 5 years, CV Sciences' Payables skyrocketed by 45571.03% in 2021 and then crashed by 3918.7% in 2025.
  • CV Sciences' Payables (Quarter) stood at $3.2 million in 2021, then fell by 29.42% to $2.3 million in 2022, then increased by 1.09% to $2.3 million in 2023, then dropped by 16.63% to $1.9 million in 2024, then plummeted by 36.94% to $1.2 million in 2025.
  • Its Payables was $1.2 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.5 million in Q1 2025.